Akao, Masaharu http://orcid.org/0000-0002-2348-7646
Yamashita, Takeshi
Suzuki, Shinya
Okumura, Ken
Sakuma, Ichiro
Ajioka, Masayoshi
Kusano, Kengo
Ohki, Takahiro
Kimura, Takeshi
Akao, Masaharu
Asakawa, Tetsuya
Okabe, Masaaki
Ogimoto, Akiyoshi
Ikeda, Takanori
Nishida, Taku
Mizukami, Akira
Tabuchi, Toshifumi
Yamashita, Takeshi
Suzuki, Yasushi
Ako, Junya
Takatsuki, Seiji
Sumimoto, Takumi
Hagiwara, Nobuhiwa
Yamada, Takahisa
Fukatani, Masahiko
Ito, Nobuhiko
Nakajima, Kohsuke
Michishige, Hiroyuki
Koretsune, Yukihiro
Kamiyama, Kenji
Sugi, Naoki
Kubo, Takaaki
Yagi, Tetsuo
Sugiura, Atsushi
Momiyama, Yukihiko
Iwao, Tetsu
Watanabe, Tetsuya
Nakanishi, Tohru
Takeishi, Yasuchika
Kameda, Kunihiko
Inoue, Teruo
Funazaki, Toshikazu
Doi, Naofumi
Higuchi, Yoshiharu
Tsuboko, Yusuke
Sato, Yoshihiro
Machii, Kazuo
Hiyoshi, Yasunaga
Harada, Masahiko
Inoko, Moriaki
Takenaka, Hiroyuki
Furukawa, Yutaka
Ando, Kenji
Nakagawa, Yoshihisa
Yoshitani, Kazuyasu
Takahashi, Mamoru
Miki, Shinji
Murakami, Tomoyuki
Inoue, Koichi
Takano, Yuzuru
Shimizu, Wataru
Arakawa, Tomoharu
Sata, Masataka
Shimizu, Shogo
Hagii, Joji
Yoshimoto, Tetsuyuki
Fujii, Shinya
Takahashi, Naohiko
Tsuji, Hikari
Nakajima, Tamio
Watanabe, Masayuki
Watanabe, Eiichi
Arikawa, Masaya
Ota, Akira
Ozaki, Masaharu
Misumi, Ikuo
Uematsu, Masaaki
Hatayama, Toru
Sato, Atsushi
Narita, Hidetoshi
Toyamori, Hiroshi
Yoshida, Kazuhiro
Furukawa, Kayoko
Komatsu, Takashi
Shimizu, Akihiko
Onodera, Tomoya
Igarashi, Morio
Fujino, Takao
Hasegawa, Shinji
Suzuki, Tomomi
Yuge, Masaru
Inoue, Takeshi
Kudo, Takeshi
Koeda, Toshihiko
Ohwada, Takayuki
Sumi, Hirokuni
Yamabe, Jinko
Ozawa, Mahito
Sugiura, Toshiyuki
Okumura, Ken
Tomita, Hirofumi
Kondo, Kazuhiko
Morikawa, Yasuhide
Haruta, Shoji
Ishida, Shuji
Shirotani, Manabu
Inoue, Fumitaka
Sato, Koji
Fujimoto, Kazuteru
Katahira, Yoshiaki
Mizukami, Akira
Matsumura, Norihiko
Tayama, Shinji
Tsunoda, Ryusuke
Ikeguchi, Shigeru
,
Funding for this research was provided by:
Bristol-Myers Squibb
Article History
Received: 10 September 2020
Accepted: 8 January 2021
First Online: 24 January 2021
Compliance with ethical standards
:
: MA received lecture fees from Pfizer, Bristol-Myers Squibb, Boehringer Ingelheim, Bayer Healthcare and Daiichi-Sankyo. TY received lecture fees from Bristol Myers Squibb, Daiichi-Sankyo, Bayer, Pfizer, Ono Pharmaceutical and Toa Eiyo and research funding from Bayer and Daiichi Sankyo. SS received research funding from Daiichi-Sankyo and Mitsubishi-Tanabe. KO received lecture fees from Daiichi-Sankyo, Boehringer Ingelheim and Johnson and Johnson.